Blood Biomarkers from Research Use to Clinical Practice: What Must Be Done? A Report from the EU/US CTAD Task Force Article

Industry Collaboration International Collaboration

cited authors

  • Angioni, D.; Delrieu, J.; Hansson, O.; Fillit, H.; Aisen, P.; Cummings, J.; Sims, J. R.; Braunstein, J. B.; Sabbagh, M.; Bittner, T.; Pontecorvo, M.; Bozeat, S.; Dage, J. L.; Largent, E.; Mattke, S.; Correa, O.; Robledo, L. M. Gutierrez; Baldivieso, V; Willis, D. R.; Atri, A.; Bateman, R. J.; Ousset, P-J; Vellas, B.; Weiner, M.

Publication Date

  • October 1, 2022

webpage

published in

category

keywords

  • Alzheimer's disease
  • amyloid
  • blood biomarkers
  • clinical trials
  • diagnostic
  • neurofilament light
  • p-tau

start page

  • 569

end page

  • 579

volume

  • 9

issue

  • 4